Category Business

Ray Therapeutics

Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease

Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease In a significant milestone for the field of regenerative medicine and vision restoration, Ray Therapeutics—a clinical-stage biotechnology company specializing in optogenetic gene therapies—has been awarded…

Read MoreRay Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease
Kashiv BioSciences

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management

Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful execution of a senior secured credit agreement with GoldenTree Asset…

Read MoreKashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management
Antibody

$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers

$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers The antibody-drug conjugate (ADC) market is poised for significant growth, with projections indicating an increase from USD 7.72 billion in the current year to USD 23.3 billion by…

Read More$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers
Investment

Novotech Secures Investment from GIC, Temasek, and TPG to Drive Global Expansion

Novotech Secures Investment from GIC, Temasek, and TPG to Drive Global Expansion Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), has announced a significant investment from leading global investors GIC and Temasek. The two firms have signed…

Read MoreNovotech Secures Investment from GIC, Temasek, and TPG to Drive Global Expansion
Ayrmid Pharma Ltd., a pioneering company in cell therapy

RoslinCT & Ayrmid Pharma Plan Strategic Partnership for Omisirge® Manufacturing

RoslinCT and Ayrmid Pharma Ltd. Plan Strategic Partnership for Omisirge® Manufacturing Ayrmid Pharma Ltd., a pioneering company in cell therapy focused on transforming cells into powerful therapeutics, and RoslinCT, a world-leading contract development and manufacturing organization (CDMO) specializing in cell…

Read MoreRoslinCT & Ayrmid Pharma Plan Strategic Partnership for Omisirge® Manufacturing